Brief: Interpace Biosciences Q2 Revenue USD 11.026 Million
09/08/2023 17:30
Aug 09 (Reuters) - Interpace Biosciences Q2 net income continuing operations USD 395 thousand. * Q2 net income USD 175 thousand * Q2 operating expenses USD 6.003 million * Q2 operating income USD 832 thousand * Q2 gross profit USD 6.835 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million